Roderick James Hay (London, United Kingdom)
Roderick James Hay is Consultant Dermatologist, Kings College Hospital, London and Professor of Cutaneous Infection, Kings College London and past Chairman of the International Foundation for Dermatology. He is a Trustee and Chairman of the Research and Grants Committee of the Dunhill Medical Trust. His first Consultant post was at the Institute of Dermatology in 1979 and clinical senior lecturer at LSHTM. He was appointed to the Chair of Cutaneous Medicine and consultant dermatologist at Guys and St Thomas in 1989. Between 1995 and 2000 he was Dean and Clinical Director of the St Johns Institute of Dermatology, London. From 2002-2007 he was Head of the School of Medicine and Dentistry and Dean of the Faculty of Medicine and Health Sciences, Queens University Belfast ( QUB ) and is an emeritus Professor of Medicine QUB. He was a non-executive director of the Eastern Health and Social Services Board (Health Authority) Northern Ireland between 2002 and 2009. He is a former President of the British Association of Dermatologists, and the British and European Societies of Medical Mycology. He was appointed a Fellow of the Academy of Medical Sciences in 2000. His research interests are pathogenesis of fungal disease, tropical dermatology and epidemiology of infectious skin disease. He coordinates the Global Burden of Disease Study Dermatology Group.
Peter Friedl (Nijmegen, Netherlands)
Peter Friedl was born and raised in Germany, received his M.D. degree from the University of Bochum in 1992 and the Ph.D. degree from the McGill University, Montreal in 1996. Since 2007 he has been directing the Microscopical Imaging Centre of the Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands and since 2011 holds a joint-faculty position at the Universtiy of Texas MD Anderson Cancer Center, Houston, TX. His research interest is the mechanisms and plasticity of cell migration in immune regulation and cancer metastasis, with emphasis on cell-matrix adhesion, pericellular proteolysis and cell-cell communication during migration. His laboratory identified pathways determining diversity and plasticity of cell migration, collective cancer cell invasion, and the contribution of migration pathways to immune defence and cancer resistance.
Alan Geller (Boston, United States of America)
For more than 25 years, I have conducted extensive research centred on health behaviour change in multiple settings including paediatric offices, clinics, and hospitals. I have conducted numerous randomised trials and worked with parents, children, and providers. My experience in epidemiology, survey development, study design, development and refinement of educational materials, health literacy, key tenets of early detection and training coincide with the major goals of the current proposal.
Eli Sprecher (Tel Aviv, Israel)
Eli Sprecher was born in Waterloo, Belgium. He moved to Israel in 1981; he received his MD and PhD degrees from the Hebrew University of Jerusalem. He specialised in dermatology at the Rambam Medical Center and spent a post-doc fellowship at Thomas Jefferson University, Philadelphia. He served at the Rambam Medical center as senior physician in the department of dermatology and as deputy director of the Rappaport Institute, Technion. He became Chair of the department of Dermatology at the Tel Aviv Medical center in 2008 and Full Professor at the Tel Aviv University in 2010. He serves as section editor for the British Journal of Dermatology and associate editor for the Journal of Investigative dermatology. He has published over 200 peer-reviewed publications and mentored over 40 students. His research interest is in the molecular genetics of skin diseases.
Constantine Stratakis (Bethesda, United States of America)
Dr. Constantine A. Stratakis did predoctoral work in Athens and Paris, France, before joining the Developmental Endocrinology Branch of the National Institute of Child Health & Human Development (NICHD) at the National Institutes of Health (NIH), Bethesda, MD. At Georgetown University Medical School, Washington, D.C., he finished a residency in Paediatrics and two fellowships, in Paediatric Endocrinology, and Medical Genetics. Between 2002 and 2014, he was the Director of the NIH Paediatric Endocrinology Fellowship Program. From 2003 to 2011 he served in various leading positions at NICHD, NIH. His research focuses on the genetic defects leading to pituitary and adrenal diseases, and his laboratory has identified a number of genes involved in pituitary adenoma formation, adrenocortical hypeprlasias and other tumours. He is the author of more than 500 publications and is currently serving in the Editorial Boards of several leading journals. Dr. Stratakis has received from the Endocrine Society the 1999 Award for Excellence in Published Clinical Research and the 2009 Ernst Oppenheimer Award, a number of NIH Merit Awards, and from a variety of Institutions a number of other honours, including an Honorary PhD from the University of Liege, Belgium. He has also been named Visiting Professor in several academic centres around the world. Dr. Stratakis is now the Scientific Director of NICHD, one of the largest Institutes of NIH.
Christopher Bunker (London, United Kingdom)
Chris Bunker is Consultant Dermatologist at University College and Chelsea & Westminster, Hospitals, London, UK. He has a personal Chair at Imperial College and University College, London, UK. He was educated at St Catharine’s College, Cambridge, UK and Westminster Medical School, London, UK and trained in Dermatology at The Middlesex and University College Hospitals, London, UK. He was awarded the Cambridge University Sir Walter Langdon-Brown prize for his MD thesis.
He is the Immediate Past-President of the British Association of Dermatologists, a past President of St John’s Hospital Dermatological Society and is the President of the Dermatology Section of the Royal Society of Medicine. He has delivered the Royal College of Physicians Ingram Lecture (twice), the Dowling Oration and the Neil Smith Lecture. He is the elected UK Board Member of the European Academy of Dermatovenereology, the Secretary of the British Skin Foundation and the President-Elect of the Dowling Club.
His clinical and research interests include toxic epidermal necrolysis (TEN), melanoma, male genital dermatoses and HIV Dermatology and he is invited to lecture on all of these topics frequently – in the UK and abroad. He has published over 320 papers, case reports, books and chapters, including on TEN. His publication metrics are: h factor 31; i10 index 121.